NCT06859944 Prospective Randomized Non-Inferiority Study Comparing Natural Cycle Frozen Embryo Transfer (NC-FET) to a New Type of Endometrial Preparation for FET: Natural Proliferative Phase (NPP-FET)
| NCT ID | NCT06859944 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasme University Hospital |
| Condition | Comparison of Pregnancy Rate (HCG+ Level) Obtained After a Replacement Embryonic in Spontaneous Cycle and Following Protocol "NPP". Comparison |
| Study Type | OBSERVATIONAL |
| Enrollment | 272 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 272 participants in total. It began in 2024-08-05 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frozen embryo replacement cycle :Two methods traditionally used: the spontaneous cycle and the artificial cycle.Now, Emergence of new protocols: NPP-FET or "Natural proliferative phase - frozen embryo transfer" Demonstrate non-inferiority between the NPP-FET and the spontaneous cycle, and superiority in terms of planning.
Eligibility Criteria
Inclusion Criteria: * Single transfer Blastocyste Exclusion Criteria: * PGT (Preimplantation genetic diagnosis) * Testicular Sperm * Donor oocytes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06859944 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Comparison of Pregnancy Rate (HCG+ Level) Obtained After a Replacement Embryonic in Spontaneous Cycle and Following Protocol "NPP". Comparison. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06859944 currently recruiting?
Yes, NCT06859944 is actively recruiting participants. Contact the research team at anne.delbaere@hubruxelles.be for enrollment information.
Where is the NCT06859944 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT06859944 clinical trial?
NCT06859944 is sponsored by Erasme University Hospital. The trial plans to enroll 272 participants.